ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

Core Insights - ImmuCell Corporation is set to report unaudited financial results for Q1 2025 on May 14, 2025, after market close [1][3] - A conference call to discuss these results is scheduled for May 15, 2025, at 9:00 AM ET [2] - The company anticipates no changes to preliminary sales results disclosed on April 8, 2025 [3] Company Overview - ImmuCell focuses on developing and marketing products that enhance the health and productivity of dairy and beef cattle [5] - The company manufactures First Defense, which provides Immediate Immunity™ to newborn calves, and is developing Re-Tain, a treatment for subclinical mastitis in dairy cows [5] Investor Information - Investors can access an updated Corporate Presentation slide deck on the company's website, which will be available after market close on May 14, 2025 [4]